Clinical Trial Update: Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and radiation distribution of Cotara in patients with recurrent glioblastoma multiforme has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Cotara

Snippet

Sponsor: Peregrine Pharmaceuticals | Conditions: Recurrent Glioblastoma Multiforme | Phase 1 | Status: COMPLETED